Aggressive Non-Hodgkin Lymphoma — Trials

Aggressive Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

648 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 182
Recruiting: 92
Ph III recruiting: 4
Growth YoY: +6.7%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (109)

clinicaltrialsPublishedShowing 1–50 of 648 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01676805	Tissue Collection for Studies of Lymph Cancer	recruiting	—	1,295	National Cancer Institute (NCI)NIH	2	Sep 28, 2026	clinicaltrials
NCT02682667	Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols	recruiting	—	500	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials